Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1352.14
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 130 EP applications Patrick John Henry Campbell has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 14, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13746448

BENZOTHIOPHENE COMPOUND, ALTERNATIVE AUTOPHAGY-INDUCING AGENT AND ANTICANCER DRUG INCLUDING BENZOTHIOPHENE COMPOUND AS ACTIVE INGREDIENT, AND METHOD FOR SCREENING FOR COMPOUNDS HAVING ANTICANCER ACTIVITY

IPC classification:
A61K 31/382, G01N 33/50, G01N 33/15, C07D 333/68, A61P 43/00, A61P 35/02, A61P 35/00
Applicant:
Tokyo Medical and Dental University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP13747275

SUBSTRATES, PEPTIDE ARRAYS, AND METHODS

IPC classification:
C12Q 1/00, C07K 1/10, C07K 1/04
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13748609

ENZYMES AND METHODS FOR CLEAVING N-GLYCANS FROM GLYCOPROTEINS

IPC classification:
A61K 38/08, A23L 1/29, C12N 15/52, C07K 7/06
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13744084

HUMAN MONOCLONAL ANTIBODIES BROADLY PROTECTIVE AGAINST INFLUENZA B VIRUS AND METHODS OF USING THE SAME

IPC classification:
A61K 39/395, G01N 33/569, C12P 21/08, C12N 15/02, C07K 16/10, A61P 31/16
Applicant:
Osaka University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13748805

GREEN SULFUR BACTERIA VARIANT AND BACTERIOCHLOROPHYLL

IPC classification:
C12P 9/00, C12N 15/09, C12N 1/21, C12N 1/20
Applicant:
Kurume University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13707529

ANTI SEZ6 ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13710247

METHOD OF ALTERING THE IMMUNDOMINANCE HIERARCHY OF HIV GAG BY DNA VACCINE EXPRESSING CONSERVED REGIONS

IPC classification:
C07K 14/16
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
University of Washington CoMotion
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13757943

SIZE-BASED ANALYSIS OF FETAL DNA FRACTION IN MATERNAL PLASMA

IPC classification:
G06F 19/20, G06F 19/18, C12Q 1/68
Applicant:
Chinese University of Hong Kong (CUHK)
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13760635

METHODS FOR ANALYZING MASSIVELY PARALLEL SEQUENCING DATA FOR NONINVASIVE PRENATAL DIAGNOSIS

IPC classification:
G06F 19/20, C12Q 1/68
Applicant:
Chinese University of Hong Kong (CUHK)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13715055

SYNTHETIC COMPOUNDS FOR VEGETATIVE ABA RESPONSES

IPC classification:
A01P 15/00, A01N 43/42
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13767407

ANTI-LAMP5 ANTIBODY AND UTILIZATION THEREOF

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07K 19/00, A61P 35/00
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13717134

GENE EXPRESSION PANEL FOR BREAST CANCER PROGNOSIS

IPC classification:
C12Q 1/68
Applicant:
Oregon Health & Science University
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13775129

PROCESS FOR PREPARATION OF BENZYLBENZENE SODIUM-DEPENDENT GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS

IPC classification:
A61K 31/7034, C07H 7/04, C07C 43/225, C07C 41/16, C07C 39/15, A61P 3/10
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP13776184

BIS-POLYMER LIPID-PEPTIDE CONJUGATES AND NANOPARTICLES THEREOF

IPC classification:
A61K 38/00
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13782257

ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES

IPC classification:
A61K 39/395, A01K 67/027, C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07K 16/28, A61P 37/08, A61P 29/00
Applicant:
Chiba University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13787593

METHOD FOR PREDICTING PROGNOSIS OF RENAL CELL CARCINOMA

IPC classification:
C12Q 1/68, C12N 15/09
Applicant:
National Cancer Center (Japan)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13787178

ANTI-CXADR ANTIBODY

IPC classification:
A61K 49/00, A61K 39/395, G01N 33/574, C12P 21/08, C12N 15/02, C07K 16/32, C07K 16/30, A61P 35/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13787381

ANTIBODIES SPECIFIC FOR CLL-1

IPC classification:
C07K 16/28
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13729224

METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS

IPC classification:
A61K 38/18, A61P 25/28, A61P 25/24, A61P 25/22, A61P 25/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
No opposition filed within time limit
EP13797956

SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR REGULATING EXPRESSION OF GENE HAVING DELIVERING FUNCTION

IPC classification:
A61K 48/00, A61K 47/48, C12N 15/113, C12N 15/09, A61P 43/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13730049

ANTI -TRANSGLUTAMINASE 2 ANTIBODIES

IPC classification:
C07K 16/40
Applicant:
LifeArc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13733322

TREATMENT FOR BONE DISEASES

IPC classification:
A61K 39/395, C07K 16/22
Applicant:
UCB Pharma S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP13813919

WHEAT WITH INCREASED GRAIN-BEARING NUMBER AND METHOD FOR PRODUCING SAME, AND CHEMICAL FOR INCREASING GRAIN-BEARING NUMBER OF WHEAT

IPC classification:
A01H 5/10, A01H 5/00, A01H 1/00, C12N 15/113, C12N 15/09
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13825402

MONOCLONAL ANTIBODY AGAINST HUMAN MIDKINE

IPC classification:
A61K 39/395, C12P 21/08, C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07K 16/46, C07K 16/18, A61P 35/00
Applicant:
Nagoya University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
No opposition filed within time limit
EP13828363

PROMOTER OF DIFFERENTIATION FROM HEPATIC PROGENITOR CELL INTO HEPATIC CELL, AND USE THEREOF

IPC classification:
C12Q 1/02, C12N 15/113, C12N 15/09, C12N 5/10, C12N 5/077
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13829120

ATTENUATED LIVE VACCINE FOR CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS AND ERVE VIRUS

IPC classification:
A61K 39/12, C12N 7/04, C12N 7/00
Applicant:
Colorado Seminary University of Denver
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13834977

METHOD FOR MAINTAINING ORGAN OR TISSUE FOR TRANSPLANTATION USE FOR LONG PERIOD

IPC classification:
A61L 27/00, A01N 1/02
Applicant:
Organ Technologies Inc.
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13836945

GENE KNOCK-IN NON-HUMAN ANIMAL

IPC classification:
A01K 67/027, G01N 33/68, G01N 33/50, G01N 33/15, C12P 21/08, C12N 15/09, C07K 16/46, C07K 16/28
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13843218

METHODS AND APPARATUSES FOR INCREASING MUCOCILIARY CLEARANCE

IPC classification:
A61M 29/02, A61B 7/00, A61B 5/00, A61B 1/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13779699

PROTEOLYTIC INACTIVATION OF SELECT PROTEINS IN BACTERIAL EXTRACTS FOR IMPROVED EXPRESSION

IPC classification:
C12N 9/50, C07K 14/47
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13854825

SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES

IPC classification:
A61K 35/34
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13855096

GEMCITABINE PRODRUGS AND USES THEREOF

IPC classification:
A61K 31/70, C07H 19/02
Agent:
Christian Lang, LangPatent
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13801947

HETERODIMERIC IMMUNOGLOBULINS

IPC classification:
A61K 39/395, C07K 19/00, C07K 16/46, C07K 16/32, C07K 16/28, C07K 16/22, C07K 16/18, A61P 19/08
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13856207

NUCLEIC ACIDS USEFUL FOR INTEGRATING INTO AND GENE EXPRESSION IN HYPERTHERMOPHILIC ACIDOPHILIC ARCHAEA

IPC classification:
C12N 15/74
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13850907

COMPLEXES OF PHOSPHINE LIGANDS COMPRISING A CARBA-CLOSO-DODECABORATE SUBSTITUENT

IPC classification:
C07F 5/02, C07B 61/00
Applicant:
University of California - Office of Technology Transfer
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13858466

RNA INTERFERENCE AGENT, METHOD FOR PRODUCING SAME, AND USE THEREOF

IPC classification:
C12Q 1/02, C12N 15/113
Applicant:
Gifu University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13857993

ANTICONVULSANT ACTIVITY OF STEROIDS

IPC classification:
A61K 47/40, A61K 31/56, A61P 25/28
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13863107

PERSONALIZED BIOMARKERS FOR CANCER

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13863207

PORPHYRIN MODIFIED TELODENDRIMERS

IPC classification:
A61K 31/74, A61B 5/00, C07D 487/22
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP13864639

COMPOSITION HAVING TISSUE REPAIRING ACTIVITY AND UTILIZATION THEREOF

IPC classification:
A61K 45/06, A61K 45/00, A61K 38/00, A61K 31/737, C12N 15/09, A61P 43/00, A61P 37/06, A61P 37/02, A61P 29/00, A61P 27/04, A61P 25/28, A61P 25/16, A61P 25/00, A61P 21/00, A61P 19/02, A61P 17/02, A61P 11/00, A61P 9/10, A61P 9/00, A61P 3/10, A61P 1/16
Applicant:
The University of Tokushima
Applicant:
Nagoya University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13867433

EICOSAPENTAENOIC ACID (EPA) FORMULATIONS

IPC classification:
A61K 36/05, A61K 31/202, A61P 25/00, A61P 9/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13866203

ANTIBODIES THAT BIND MEMBRANE-BOUND IL1RAP

IPC classification:
C07K 16/28
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14743597

MICROORGANISM FOR PRODUCTION OF CHEMICALS DERIVED FROM ACETYL-COA

IPC classification:
C12P 19/32, C12P 13/14, C12N 1/21
Applicant:
Mitsui Chemicals Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14743436

MICROORGANISM HAVING CARBON DIOXIDE FIXATION CYCLE INTRODUCED THEREINTO

IPC classification:
C12P 1/00, C12N 15/09, C12N 1/21
Applicant:
Mitsui Chemicals Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15170550

SINGLE NUCLEOTIDE POLYMORPHISM IN IGF2 FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14705881

METHODS OF SELECTING COMBINATION THERAPY FOR COLORECTAL CANCER PATIENTS

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
EXAMINATION IN PROGRESS
EP14705880

DRUG SELECTION FOR COLORECTAL CANCER THERAPY USING RECEPTOR TYROSINE KINASE PROFILING

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
EXAMINATION IN PROGRESS
EP14706699

DRUG SELECTION FOR NON-SMALL CELL LUNG CANCER THERAPY

IPC classification:
C12Q 1/68
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
The patent has been granted
EP14748891

ANTIBODIES TO HUMAN NRG1 PROTEIN

IPC classification:
C12P 21/08, C12N 5/10, C07K 16/18, A61P 35/00, A61K 39/395, C12N 15/09
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15163893

COMBINATIONS OF POLYMORPHISMS FOR DETERMINING ALLELE-SPECIFIC EXPRESSION OF IGF2

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14757745

ANTIBODY AGAINST INSOLUBLE FIBRIN

IPC classification:
G01N 33/53, C12N 15/02, C07K 16/36
Applicant:
National Cancer Center (Japan)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14723908

MODIFIED PYR/PYL RECEPTORS ACTIVATED BY ORTHOGONAL LIGANDS

IPC classification:
A01N 25/00, C12N 15/82
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14764952

TISSUE AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS AND METASTASIS-PREDICTIVE POTENTIAL IN COLORECTAL CANCER

IPC classification:
C40B 40/06, C12P 19/34, C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15183030

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITING IL-17 ACTIVITY

IPC classification:
A61P 37/00, A61K 47/48, A61K 39/395
Applicant:
UCB Biopharma SPRL
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14763923

PEPTIDES HAVING REDUCED TOXICITY THAT STIMULATE CHOLESTEROL EFFLUX

IPC classification:
A61K 38/00
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14782359

SOIL METABOLIZABLE CYANAMIDE PESTICIDE COMPOSITIONS

IPC classification:
A01N 59/24
Applicant:
Auburn University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14727670

THE USE OF LAMBDA-GAM PROTEIN IN RIBOSOMAL DISPLAY TECHNOLOGY

IPC classification:
C12N 15/10
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15182430

ANTIBODY SPECIFICITY TRANSFER USING MINIMAL ESSENTIAL BINDING DETERMINANTS

IPC classification:
C12Q 1/70, G01N 33/53, C07K 16/12, C07K 16/00, A61K 39/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14787867

FUNCTIONAL MONOCLONAL ANTIBODY AGAINST HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR

IPC classification:
C12N 15/09, C12N 5/10, A61P 35/00, A61K 39/395, C07K 16/22
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP15177122

COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS

IPC classification:
C12N 5/00
Applicant:
The Scripps Research Institute
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14792250

PROGNOSIS OF RESPONSE TO TREATMENT WITH ANTI-TNF-ALPHA IN PATIENTS WITH RHEUMATOID ARTHRITIS

IPC classification:
C12Q 1/68
Applicant:
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14794936

NUCLEIC ACID OF CODED GPC3 CHIMERIC ANTIGEN RECEPTOR PROTEIN AND T LYMPHOCYTE EXPRESSING GPC3 CHIMERIC ANTIGEN RECEPTOR PROTEIN

IPC classification:
C07H 21/00, C07K 16/28, C12N 15/63, C12N 7/00, C12N 5/10, C12N 15/09
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
Examination is in progress
EP14794723

ANTIBIOTIC AND ANTI-PARASITIC AGENTS THAT MODULATE CLASS II FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE

IPC classification:
C07D 215/00, C07D 413/00, A01N 43/42, A61K 31/535
Applicant:
Regis University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14728658

METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF COLORECTAL CANCER PATIENTS

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
The patent has been granted
EP14805118

METHOD FOR DEBITTERING OLIVES

IPC classification:
A23L 11/30
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14733761

A METHOD OF BIOLOGICAL TARGET DETECTION USING A NANOPORE AND A FUSION PROTEIN BINDING AGENT

IPC classification:
C12Q 1/68, G01N 33/487
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14733677

SINGLE DOMAIN ANTIBODY DISPLAY

IPC classification:
G01N 33/50, A61K 39/00, C12N 15/62, C07K 14/005, C07K 16/46
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14803370

HETEROMULTIMERS WITH REDUCED OR SILENCED EFFECTOR FUNCTION

IPC classification:
C12N 15/13, C07K 16/28, C07K 16/00, A61K 39/395, C07K 16/46
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14813532

CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS

IPC classification:
A61K 9/00
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14818118

MULTIPLEXED BIOMARKER QUANTITATION BY NANOPORE ANALYSIS OF BIOMARKER-POLYMER COMPLEXES

IPC classification:
C12Q 1/68, G01N 33/68, G01N 33/53, G01N 33/50, G01N 33/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15188222

DIARYLTHIOHYDANTOIN COMPOUNDS USEFUL FOR THE TREATMENT OF A HYPERPROLIFERATIVE DISORDER

IPC classification:
A61P 35/00, A61K 31/4166, C07D 233/86
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14826104

MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8 REGULATES FATTY ACID UPTAKE

IPC classification:
A61P 1/00
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14838211

METHODS FOR EVALUATING AND SCREENING S1P1 RECEPTOR AGONISTS

IPC classification:
C07K 14/705, G01N 33/15, A61P 43/00, A61P 37/06, A61K 45/00, A61K 31/397, G01N 33/50
Applicant:
Meiji Seika Pharma Co., Ltd (Meiji Seika Kabushiki-gaisha)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14839864

METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS

IPC classification:
C12N 5/10, C12N 15/09
Applicant:
Gifu University
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14838934

MOLECULE DETECTION USING BORONIC ACID SUBSTITUTED PROBES

IPC classification:
C12N 9/00, C12P 21/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14845308

METHODS OF TREATMENT USING BIS-POLYMER LIPID-PEPTIDE CONJUGATES AND NANOPARTICLES THEREOF

IPC classification:
A61K 47/42
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14846696

SYSTEMS AND METHODS OF TREATMENT USING INTERVENTION AND TASKING DETERMINATION

IPC classification:
G06Q 50/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14852607

PREPARATION OF HYDROXY-BENZYLBENZENE DERIVATIVES

IPC classification:
C07C 309/29, C07C 41/01, C07C 37/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14852519

NON-NATURAL AMINO ACID tRNA SYNTHETASES FOR PARA-METHYLAZIDO-L-PHENYLALANINE

IPC classification:
C07K 17/00, C07K 14/00, C07K 1/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14852695

DRUG FOR PREVENTION OR TREATMENT OF SPINOCEREBELLAR DEGENERATION

IPC classification:
C12Q 1/68, C12Q 1/48, C12Q 1/25, C12N 15/09, G01N 33/50, G01N 33/15, A61P 25/00, A61K 48/00, A61K 45/00, A61K 31/553, A61K 31/55, A61K 31/5377, A61K 31/519, A61K 31/4709, A61K 31/4545, A61K 31/4535, A61K 38/00
Applicant:
Tokyo Medical and Dental University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14789990

SYNTHESIS OF 1-ALKYL-2-AMINO-IMIDAZOL-5-CARBOXYLIC ACID ESTER VIA CALPHA-SUBSTITUTED N-ALKYL-GLYCINE ESTER DERIVATIVES

IPC classification:
C07F 9/22, C07D 317/12
Applicant:
Merck Patent GmbH
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14855465

COMPOUNDS FOR USE IN PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES AND PAIN

IPC classification:
C07D 515/02, C07D 498/02
Applicant:
Academia Sinica
Agent:
Charrier Rapp & Liebau
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP16150667

SHP-2 GENE MUTATIONS IN MELANOMA

IPC classification:
C07K 14/435, G01N 33/53, C07H 21/04, C07H 21/02, C12P 19/34, C12Q 1/68
Applicant:
University of California
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION REQUESTED
EP14857072

TREATMENT OF METASTATIC PROSTATE CANCER

IPC classification:
A61K 31/165, C07K 14/54, A61K 38/17, A61K 31/40, A61K 38/00
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14795928

ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 47/48
Applicant:
Pfizer Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16157900

GANODERMA LUCIDUM STRAIN SUITABLE FOR LARGE-SCALE LIQUID FERMENTATION CULTURE, METHOD OF MUTATION BREEDING THE SAME, AND APPLICATION THEREOF

IPC classification:
C12R 1/645, C12R 1/885, C12N 1/14, A01H 4/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14859656

ANTIBODY HAVING BROAD NEUTRALIZING ACTIVITY IN GROUP 1 INFLUENZA A VIRUS

IPC classification:
C12P 21/08, C12N 5/10, C07K 16/10, A61P 31/16, A61K 39/395, C12N 15/09
Applicant:
Osaka University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14862612

DUPLICATING DNA WITH CONTIGUITY BARCODES FOR GENOME AND EPIGENOME SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14863514

OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS

IPC classification:
C07D 471/04, A61K 31/4375, A61K 31/4162
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14851833

NOVEL ALKYLATING AGENT FOR ALKYLATING TARGET WITH DRIVER ONCOGENE MUTATION

IPC classification:
C12N 15/09, C08L 77/00, A61P 35/00, A61K 47/48, A61K 47/34, A61K 31/403, C07D 403/14
Applicant:
Kyoto University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14821000

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS G PROTEIN FRAGMENTS

IPC classification:
A61K 39/00, C07K 14/05, A61K 39/155
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14870595

CANCER DETECTION METHOD USING SENSE OF SMELL OF NEMATODE

IPC classification:
G01N 33/493, G01N 33/00
Applicant:
Kyushu University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP14872472

CONDUCTIVE HYDROGELS FOR AFFINITY SENSING

IPC classification:
G01N 27/327
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14875056

METHOD FOR DIAGNOSIS OF ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, DIAGNOSTIC AGENT, THERAPEUTIC AGENT, AND SCREENING METHOD FOR SAID AGENTS

IPC classification:
G01N 33/50, G01N 33/15, C12Q 1/48, A61P 25/28, A61K 45/00, G01N 33/68
Applicant:
Tokyo Medical and Dental University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15737917

THERAPEUTIC PHARMACEUTICAL COMPOSITION EMPLOYING ANTI-SLC6A6 ANTIBODY

IPC classification:
C12N 15/09, C07K 16/28, A61P 35/00, A61P 15/00, A61P 1/00, A61K 51/00, A61K 45/00, A61K 39/395
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP15741076

SELF-ASSEMBLED BETA SOLENOID PROTEIN SCAFFOLDS

IPC classification:
C12N 9/14, C07K 14/47
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14705225

CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES

IPC classification:
A61P 9/00, A61P 3/06, A61K 31/506
Applicant:
Mitsubishi Tanabe Pharma Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16171151

DIARYLHYDANTOIN COMPOUNDS AS ANDROGEN RECEPTOR ANTAGONISTS FOR TREATMENT OF CANCER

IPC classification:
C07D 233/88, C07D 233/84, C07D 233/72, C07D 403/10, C07D 403/04, C07D 401/04, A61P 35/00, C07D 233/86, C07D 235/02, A61K 31/4166, A61K 31/4184
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
Request for examination was made
EP15751793

SELECTIVE PHOTO ACTIVATION OF AMINO ACIDS FOR SINGLE STEP PEPTIDE COUPLING

IPC classification:
C07K 1/10, C07K 1/04
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15708565

VACCINES BASED ON HEPATITIS B CORE ANTIGENS

IPC classification:
A61K 39/385, A61K 39/29, A61K 39/12, A61K 39/02
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15752216

FORMULATIONS FOR SMALL INTESTINAL DELIVERY

IPC classification:
A61K 39/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16183642

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISM AND PROSTATE CANCER

IPC classification:
A61K 45/06, A61K 31/4166, A61P 35/04, A61P 35/00, A61K 31/567, A61K 31/573, A61K 31/569, A61K 31/437, A61K 31/00, A61K 38/00
Applicant:
University of Chicago
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16183850

ALLOGRAFTS COMBINED WITH TISSUE DERIVED STEM CELLS FOR BONE HEALING

IPC classification:
A61L 27/54, A61L 27/36, A61K 35/38, A61K 35/12, A01N 1/02, C12N 5/0775, A61K 47/02, A61L 27/38, A61L 27/12
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION PUBLISHED
EP15761367

TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS

IPC classification:
C07D 257/08, A61K 38/14
Applicant:
University of California
Applicant:
The State University of New York
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15752232

METHOD FOR PREDICTING RESPONSIVENESS TO CANCER TREATMENT USING p300-INHIBITING COMPOUND

IPC classification:
G01N 33/50, G01N 33/15, C12Q 1/68, A61P 35/00, C12N 15/09
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
National Cancer Center (Japan)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15765883

MICROORGANISMS PRODUCING L-AMINO ACIDS AND PROCESS FOR PRODUCING L-AMINO ACIDS USING THE SAME

IPC classification:
C12P 13/04, C12N 15/70, C12N 1/21
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15764058

MICROORGANISMS HAVING ENHANCED L-AMINO ACIDS PRODUCTIVITY AND PROCESS FOR PRODUCING L-AMINO ACIDS USING THE SAME

IPC classification:
C12P 13/04, C12N 15/70, C12N 1/21
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15769869

APTAMER INHIBITING BIOLOGICAL ACTIVITY OF AUTOTAXIN BY BINDING WITH AUTOTAXIN, AND USE THEREOF

IPC classification:
G01N 33/566, G01N 33/53, C12Q 1/68, C12N 15/115, A61P 43/00, A61K 48/00, A61K 45/00, A61K 31/7088, C12N 15/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15767725

APTAMER FOR FGF2 AND USE THEREOF

IPC classification:
A61P 37/08, A61P 37/06, A61P 35/00, A61P 29/00, A61P 19/02, A61P 9/00, A61K 31/712, A61K 31/7088, C12N 15/115
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15768790

TRANSESTERIFICATION REACTION BY MEANS OF IRON CATALYST

IPC classification:
C07B 61/00, C07C 69/78, C07C 69/618, C07C 69/612, C07C 67/03, B01J 31/22
Applicant:
Kyushu University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15776244

O-SUCCINYLHOMOSERINE PRODUCING MICROORGANISM AND METHOD FOR PRODUCING O-SUCCINYLHOMOSERINE USING SAME

IPC classification:
C12P 13/06, C12N 15/70, C12N 15/53, C12N 1/21
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15779171

BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF

IPC classification:
C07K 7/06, A61K 39/385, A61K 38/00
Applicant:
University of California - Office of Technology Transfer
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16174632

USE OF IL-15-IL-15 RECEPTOR HETERODIMERS TO TREAT LYMPHOPENIA

IPC classification:
A61K 38/17, C07K 14/715, C07K 14/54, A61K 45/06, A61P 37/04, A61K 48/00, A61K 47/50, A61K 38/20
Agent:
Sarah Louise Thompson, Novartis Pharma AG
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
Request for examination was made
EP15783801

APTAMER FOR BONDING TO AUTOTAXIN AND INHIBITING BIOLOGICAL ACTIVITY OF AUTOTAXIN, AND USE FOR SAME

IPC classification:
A61P 43/00, A61P 11/00, A61K 48/00, A61K 45/00, A61K 31/7105, C12N 15/115
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14747765

TARGET DETECTION WITH NANOPORE

IPC classification:
C12Q 1/68, G01N 33/487
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16194631

VARIANT ACTIVIN RECEPTOR POLYPEPTIDES AND USES THEREOF

IPC classification:
A61K 38/17, C07K 14/71, C12N 5/10, C12N 15/861, C12N 15/12
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
Request for examination was made
EP15792849

SCAFFOLD DATA STORAGE AND TARGET DETECTION IN A SAMPLE USING A NANOPORE

IPC classification:
G01N 33/53, G01N 33/487, C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15793383

COMPOSITIONS AND METHODS FOR SINGLE-MOLECULE CONSTRUCTION OF DNA

IPC classification:
C12N 15/10
Applicant:
University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15796107

CENTROMERE/KINETOCHORE PROTEIN GENES FOR CANCER DIAGNOSIS, PROGNOSIS AND TREATMENT SELECTION

IPC classification:
G01N 33/574, G01N 33/53, C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15727042

SEQUENCING PROCESS

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
The patent has been granted
EP15727838

COMPOSITIONS AND METHODS OF DELIVERING TREATMENTS FOR LATENT VIRAL INFECTIONS

IPC classification:
A61P 31/22, A61K 31/7088, C12N 15/113
Applicant:
Stanford Office of Technology Licensing
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15729007

COMPOSITIONS AND METHODS TO TREAT LATENT VIRAL INFECTIONS

IPC classification:
A61P 31/22, A61K 31/7088, C12N 15/113
Applicant:
Stanford Office of Technology Licensing
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15729008

COMPOSITIONS AND METHODS OF DELIVERING TREATMENTS FOR LATENT VIRAL INFECTIONS

IPC classification:
A61P 31/22, A61K 31/7088, C12N 15/113
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15803039

ARTIFICIAL CATALYST SYSTEM CAPABLE OF SUBSTITUTING FOR IN VIVO ACYLATION FUNCTION

IPC classification:
C12N 15/09, A61P 43/00, A61P 35/00, A61K 47/50, A61K 38/00, A61K 31/4409, A61K 31/16, C07K 7/00
Applicant:
University of Tokyo
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15807343

STABLE AQUEOUS ADALIMUMAB PREPARATION

IPC classification:
A61P 29/00, A61P 19/02, A61P 17/06, A61P 1/04, A61K 47/22, A61K 47/02, A61K 9/08, A61K 39/395
Applicant:
Meiji Seika Pharma Co., Ltd (Meiji Seika Kabushiki-gaisha)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15806561

METHOD FOR JUDGING PROTEIN INTERACTION

IPC classification:
C12Q 1/02, C12N 15/09
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15818940

RECOMBINANT MICROORGANISM PRODUCING QUINOLINIC ACID AND METHOD FOR PRODUCING QUINOLINIC ACID USING SAME

IPC classification:
C12P 17/10, C12N 15/09, C12N 1/21
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15757005

THERAPY SELECTION FOR PSORIASIS AND PSORIATIC ARTHRITIS

IPC classification:
C12Q 1/68
Applicant:
Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
Applicant:
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15767345

PROCESS FOR PREPARING SYNTHETIC INTERMEDIATES FOR PREPARING TETRAHYDROQUINOLINE DERIVATIVES

IPC classification:
C07D 401/12, C07D 215/42
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15767349

PHARMACEUTICAL COMPOSITION AND THERAPEUTIC COMBINATION COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND HMG CoA REDUCTASE INHIBITORS

IPC classification:
A61P 9/00, A61K 31/513
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature